Ginkgo Bioworks Holdings, Inc. (DNA)
12.41
-2.57
(-17.16%)
USD |
NYSE |
Oct 06, 16:00
12.38
-0.03
(-0.24%)
Pre-Market: 05:01
Ginkgo Bioworks Holdings Profit Margin (Quarterly) : -284.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -284.4% |
| March 31, 2026 | -390.6% |
| December 31, 2025 | -241.8% |
| September 30, 2025 | -207.9% |
| June 30, 2025 | -135.9% |
| March 31, 2025 | -217.9% |
| December 31, 2024 | -245.2% |
| September 30, 2024 | -63.34% |
| June 30, 2024 | -386.4% |
| March 31, 2024 | -437.3% |
| December 31, 2023 | -609.1% |
| September 30, 2023 | -546.4% |
| Date | Value |
|---|---|
| June 30, 2023 | -215.1% |
| March 31, 2023 | -254.0% |
| December 31, 2022 | -177.2% |
| September 30, 2022 | -1.01K% |
| June 30, 2022 | -463.7% |
| March 31, 2022 | -351.9% |
| December 31, 2021 | -1.08K% |
| September 30, 2021 | -131.9% |
| June 30, 2021 | -124.8% |
| March 31, 2021 | -169.6% |
| December 31, 2020 | -144.7% |
| September 30, 2020 | -196.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sotera Health Co. | 16.69% |
| CareDx, Inc. | 83.85% |
| BillionToOne, Inc. | 7.36% |
| Quest Diagnostics, Inc. | 10.94% |
| Labcorp Holdings, Inc. | 8.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.94% |
| Return on Assets | -26.50% |
| Return on Invested Capital | -31.70% |
| Gross Profit Margin (Quarterly) | 30.37% |
| Operating Margin (Quarterly) | -285.0% |
| Return on Net Operating Assets | -48.49% |